01973.HK
Tian Tu Capital Co Ltd
HKSE · Financial Services · Asset Management · CN
HKD 1.95
+6.85%Sep 3, 2026, 00:24 UTC
Zhejiang Qilin Zhengwei Medical Technology Co., Ltd. (KylinWay), a hydrogen molecule anti-aging new materials company, completed a Series A financing of tens of millions of RMB, led by the Meili Linghang Fund under Tiantu Investment.
Aug 27, 2026, 10:27 UTC
Tiantu Capital proposed an interim dividend of 0.15 RMB per share.
Source:Aug 27, 2026, 10:27 UTC
Tiantu Capital reported interim results for the six months ended June 2026, with net profit of 72.235 million RMB, down 4.96% year-on-year, and revenue of 2.442 million RMB, down 82.8%.
Source: